glp 1 and multiple sclerosis GLP-1 drugs like Ozempic are proving effective in a variety of applications beyond managing diabetes weight loss. On Real Talk MS, Dr. Ellen Mowry shares early findings from a clinical trial You might know them as

Molecular consequences of SARS-CoV-2 liver tropism

Page reviewed by Dr

What is cagrilintide and how does it differ from semaglutide Cagrilintide: Long-acting amylin analog What cagrilintide is: Synthetic analog of amylin (human hormone) Long-acting formulation (weekly dosing) Developed by Novo Nordisk Currently in Phase 3 clinical trials Not yet FDA approved (as of 2024) Paired with semaglutide as "CagriSema" How amylin works naturally: Co-secreted with insulin from pancreatic beta cells Released after meals Slows gastric emptying (food stays in stomach longer) Reduces glucagon secretion Signals satiety to brain Regulates postprandial glucose Cagrilintide's mechanisms: Mimics natural amylin but lasts much longer Dramatically slows gastric emptying Increases satiety and fullness Reduces food intake Lowers postprandial glucose Works on amylin receptors (different from GLP-1) Primary benefits: Powerful appetite suppression Extended feeling of fullness Reduced meal frequency Lower caloric intake Glucose regulation Complements GLP-1 action Learn about peptides , how peptides work , and what are peptides used for in our foundational guides

This patient had the following procedure(s) done: Abdominoplasty / Tummy Tuck Hernia Repair 41 year old mother of 3 before and 7 months after abdominoplasty and flank liposuction